SCHEMBL29488189

SCHEMBL29488189

Cc1cccc(NC(=S)NN)c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.68
MAPT P10636 3/20 0.67
GAA P10253 2/20 0.67
IDO1 P14902 5/20 0.64
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
NPSR1 Q6W5P4 2/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C19 P33261 1/20 0.63
ALDH1A1 P00352 1/20 0.61
HPGD P15428 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
ALOX12 P18054 1/20 0.58
POLB P06746 1/20 0.56
HTT P42858 1/20 0.56
RAB9A P51151 1/20 0.56
HSD17B10 Q99714 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27860201 1.00 CYP1A2 (0.68) CYP1A2MAPTGAAIDO1MEN1
SCHEMBL9453941 0.88 MEN1 (0.77) CYP1A2MAPTGAAMEN1KMT2A
SCHEMBL30557461 0.88 MEN1 (0.77) CYP1A2MAPTGAAMEN1KMT2A
SCHEMBL11839367 0.83 KMT2A (0.65) CYP1A2MAPTGAAMEN1KMT2A
SCHEMBL11674611 0.83 KMT2A (0.75) CYP1A2MAPTGAAMEN1KMT2A
SCHEMBL1886408 0.81 CYP1A2 (1.00) CYP1A2MAPTGAAMEN1KMT2A
SCHEMBL6819398 0.81 MAPT (0.71) CYP1A2MAPTGAAMEN1KMT2A
SCHEMBL27834667 0.80 MAPT (1.00) MAPTGAAIDO1MEN1KMT2A
SCHEMBL16566480 0.79 MEN1 (0.80) CYP1A2MAPTGAAIDO1MEN1
SCHEMBL5451724 0.79 SMN1; SMN2 (0.66) CYP1A2MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025046420-A1 COMPOUND TARGETING EGR-1 AND USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS 주식회사 아제라메디 2025-03-06 WO disclosed
WO-2022086079-A1 DERIVATIVE OF SEMICARBAZONE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF 고려대학교 산학협력단 2022-04-28 WO disclosed